Methoxydienone
Product Description
China Resources Zizhu
-
CN
-
2015On CPHI since
Company types
Categories
Specifications
China Resources Zizhu
-
CN
-
2015On CPHI since
Company types
More Products from China Resources Zizhu (79)
-
Product Levonorgestrel(0.15mg) and Ethinylestradiol(0.03mg) Tablets (21+7 tablets)
China Resources Zizhu Pharmaceutical Co. Ltd provides wide range of women health care products which includes levonorgestrel(0.15mg) and ethinylestradiol(0.03mg) tablets (21+7 tablets). The active tablet is a compound preparation. Each active tablet contains 0.15 mg of levonorgestrel and 0.03 mg of ethinyl... -
Product Levonorgestrel(6mg) and Quinestrol(3mg)Tablets
China Resources Zizhu Pharmaceutical Co. Ltd provides wide range of women health care products which includes levonorgestrel(6mg) and quinestrol(3mg)tablets. Each tablet contains 6 mg of levonorgestrel and 3 mg of quinestrol. Usage and dosage: the initial administration should be taken after lunch on the f... -
Product Lidocaine Hydrochloride Gel
China Resources Zizhu Pharmaceutical Co. Ltd provides wide range of anesthetic products which includes lidocaine hydrochloride gel. Dosage: 20ml for cystoscopy, biopsy under cystoscope, urethral catheterization, foreign body dislodgment, laser therapy, electrocautery, and lithotripsy. 10ml-15ml for urethra... -
Product Lynestrenol
China Resources Zizhu Pharmaceutical Co. Ltd provides wide range of api's which includes lynestrenol. Contact us for more information. -
Product Medroxyprogesterone Acetate
China Resources Zizhu Pharmaceutical Co. Ltd provides wide range of api's which includes medroxyprogesterone acetate. Contact us for more information. -
Product Mestranol
China Resources Zizhu Pharmaceutical Co. Ltd provides wide range of api's which includes mestranol. Contact us for more information. -
Product Methyldienedione
China Resources Zizhu Pharmaceutical Co. Ltd provides wide range of intermediates which includes methyldienedione. Contact us for more information. -
Product Mifepristone
China Resources Zizhu Pharmaceutical Co. Ltd provides wide range of api's which includes mifepristone. Contact us for more information. -
Product Mifepristone Capsules (5mg)
China Resources Zizhu Pharmaceutical Co. Ltd provides wide range of women health care products which includes mifepristone capsules (5mg). Usage and dosage: recommended usage and dosage: for the healthy early pregnant woman after menolipsis for not more than 49 days, orally take mifepristone capsules 25-50... -
Product Mifepristone Tablets (10mg)
China Resources Zizhu Pharmaceutical Co. Ltd provides wide range of women health care products which includes mifepristone tablets (10mg). Usage and dosage: to be taken orally, within 72 hours after sexual intercourse without protection or with contraceptive failure. Take one mifepristone tablet on an empt... -
Product Mifepristone Tablets (200mg)
China Resources Zizhu Pharmaceutical Co. Ltd provides wide range of women health care products which includes mifepristone tablets (200mg). Usage and dosage: for healthy early-pregnant women within 49 days after menolipsis, take 1 mifepristone tablets (200mg) orally once on an empty stomach or 2 hours afte... -
Product Mifepristone Tablets (25mg)
China Resources Zizhu Pharmaceutical Co. Ltd provides wide range of women health care products which includes mifepristone tablets (25mg). Usage and dosage: the healthy early pregnant woman within 49 days menolipsis takes 1-2 mifepristone tablets (25mg-50mg) orally on an empty stomach or 2 hours after taki...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance